UOC di Nutrizione Clinica, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
UOC di Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.
Nutrients. 2020 Mar 29;12(4):944. doi: 10.3390/nu12040944.
Inflammatory bowel disease (IBD) is a chronic relapsing-remitting systemic disease of the gastrointestinal tract, characterized by an inflammatory process that requires lifelong treatment. The underlying causes of IBD are still unclear, as this heterogeneous disorder results from a complex interplay between genetic variability, the host immune system and environmental factors. The current knowledge recognizes diet as a risk factor for the development of IBD and attributes a substantial pathogenic role to the intestinal dysbiosis inducing an aberrant mucosal immune response in genetically predisposed individuals. This review focused on the clinical evidence available that considers the impact of some nutrients on IBD onset and the role of different diets in the management of IBD and their effects on the gut microbiota composition. The effects of the Specific Carbohydrate Diet, low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, gluten free diet, anti-inflammatory diet and Mediterranean diet are investigated with regard to their impact on microbiota and on the evolution of the disease. At present, no clear indications toward a specific diet are available but the assessment of dysbiosis prior to the recommendation of a specific diet should become a standard clinical approach in order to achieve a personalized therapy.
炎症性肠病(IBD)是一种慢性复发性胃肠道系统疾病,其特征是炎症过程需要终身治疗。IBD 的根本原因仍不清楚,因为这种异质性疾病是遗传变异性、宿主免疫系统和环境因素之间复杂相互作用的结果。目前的知识将饮食视为 IBD 发展的危险因素,并认为肠道菌群失调在易感个体中诱导异常黏膜免疫反应具有重要的致病作用。本综述重点关注了现有临床证据,这些证据考虑了某些营养素对 IBD 发病的影响,以及不同饮食在 IBD 管理中的作用及其对肠道微生物群组成的影响。研究了特定碳水化合物饮食、低可发酵寡糖、双糖、单糖和多元醇(FODMAP)饮食、无麸质饮食、抗炎饮食和地中海饮食对微生物群和疾病演变的影响。目前,尚无明确的特定饮食指征,但在推荐特定饮食之前评估菌群失调应成为标准的临床方法,以实现个体化治疗。